DAVANGERE vs MAXHEALTH: Stock Comparison

Head-to-head financial and trading comparison between Davangere Sugar Company Limited (DAVANGERE) and Max Healthcare Institute Limited (MAXHEALTH) in the Cross-Sector Peers sector.

DAVANGERE

NSE: DAVANGERE
Davangere Sugar Company Limited
₹2.26
1Y Return: -38.59%
52W High: ₹4.40
52W Low: ₹1.75
Annual Volatility: 71.99%
Check DAVANGERE Trade Fees →

MAXHEALTH

NSE: MAXHEALTH
Max Healthcare Institute Limited
₹883.80
1Y Return: -12.61%
52W High: ₹1,153.40
52W Low: ₹873.40
Annual Volatility: 31.96%
Check MAXHEALTH Trade Fees →

Key Metrics Comparison Table

MetricDAVANGEREMAXHEALTHEdge / Winner
Current Market Price (CMP) ₹2.26 ₹883.80 —
1-Year Price Return -38.59% -12.61% MAXHEALTH (25.98% higher)
52-Week High ₹4.40 ₹1,153.40 —
52-Week Low ₹1.75 ₹873.40 —
30-Day Annualized Volatility 71.99% 31.96% MAXHEALTH (Steadier)
30-Day Average Daily Volume 22,479,894 2,642,110 DAVANGERE (Higher Liquidity)
Statutory Cost to Trade ₹1 Lakh ₹118.50 ₹118.50 Identical statutory tariff

Frequently Asked Questions

Between DAVANGERE and MAXHEALTH, which stock gave better returns over the last year?

MAXHEALTH has outperformed DAVANGERE over the past 12 months with a gain of -12.61% compared to -38.59%.

Which stock is less volatile: DAVANGERE or MAXHEALTH?

MAXHEALTH demonstrated lower price volatility (31.96% annualized) compared to DAVANGERE (71.99%). Lower volatility generally indicates steadier price action during market downturns.

What is the statutory cost to buy ₹1,00,000 of DAVANGERE vs MAXHEALTH?

Statutory exchange and government charges (STT, NSE turnover fees, SEBI fee, Stamp duty, and GST) are identical for delivery purchases of equal rupee value across both stocks, totaling approximately ₹118.50 on discount brokers offering zero delivery brokerage (like Zerodha or Dhan).

Are DAVANGERE and MAXHEALTH direct sector competitors?

Yes, both companies operate within the Cross-Sector Peers sector in India and are actively tracked as sector peers by institutional and retail market participants.